Buy One Get One free -Llimited Time Offer X
Imitop is a commercial drug that is prescribed in the form of Injection. Other than this, Imitop has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Imitop is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Imitop have been listed ahead. Normally, these side effects of Imitop are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Imitop has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Imitop has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Imitop related warnings section.
Imitop is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Kidney Disease are examples of such conditions. Other contraindications of Imitop have been discussed in the sections ahead.
Besides this, Imitop may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Imitop is safe while driving, and is is addictive in nature.
Imitop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Imitop is used -
Severe
Moderate
Mild
Is the use of Imitop safe for pregnant women?
Imitop may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Imitop again without your doctor's advice.
Is the use of Imitop safe during breastfeeding?
Breastfeeding women may feel side effects of Imitop. If you see any side effects, stop taking Imitop immediately and talk to your doctor. Take Imitop again, only after your doctor's advice.
What is the effect of Imitop on the Kidneys?
There may be some adverse effects on kidney after taking Imitop. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Imitop on the Liver?
Imitop can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Imitop on the Heart?
Imitop has very mild side effects on the heart.
Imitop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imitop unless your doctor advises you to do so -
Is this Imitop habit forming or addictive?
Imitop is not addictive in nature.
Interaction between Food and Imitop
Imitop may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Imitop
Consumption of alcohol and Imitop together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678